These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 15931928)
21. Prolonged delirium with psychotic features from omega conotoxin toxicity. Obafemi A; Roth B Pain Med; 2013 Mar; 14(3):447-8. PubMed ID: 23383992 [No Abstract] [Full Text] [Related]
22. Ziconotide: a clinical update and pharmacologic review. Pope JE; Deer TR Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340 [TBL] [Abstract][Full Text] [Related]
23. Sea snails help neuropathic pain. AIDS Patient Care STDS; 2005 Mar; 19(3):204-5. PubMed ID: 15798388 [No Abstract] [Full Text] [Related]
24. Ziconotide-induced psychosis: a case report. Phan SV; Waldfogel JM Gen Hosp Psychiatry; 2015; 37(1):97.e11-2. PubMed ID: 25459190 [TBL] [Abstract][Full Text] [Related]
25. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507 [TBL] [Abstract][Full Text] [Related]
26. Intrathecal therapy with ziconotide: clinical experience and considerations on its use. Vitale V; Battelli D; Gasperoni E; Monachese N Minerva Anestesiol; 2008 Dec; 74(12):727-33. PubMed ID: 19034250 [TBL] [Abstract][Full Text] [Related]
27. Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases. Grajny K; Durphy J; Adam O; Azher S; Gupta M; Molho E Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():37. PubMed ID: 33101763 [TBL] [Abstract][Full Text] [Related]
28. An effective treatment of severe complex regional pain syndrome type 1 in a child using high doses of intrathecal ziconotide. Stanton-Hicks M; Kapural L J Pain Symptom Manage; 2006 Dec; 32(6):509-11. PubMed ID: 17157748 [No Abstract] [Full Text] [Related]
29. [Pain relief directly in the CNS]. Dahm P; Lundborg C Lakartidningen; 2008 Sep 24-30; 105(39):2683-8. PubMed ID: 18846877 [No Abstract] [Full Text] [Related]
30. [New medications; ziconotide]. Cohen AF; van Bronswijk H Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2427-8. PubMed ID: 17131701 [TBL] [Abstract][Full Text] [Related]
32. Statistical evaluation of the chemical stability of ziconotide solutions during simulated intrathecal administration. Shields DE; Liu W; Gunning K; Montenegro R J Pain Symptom Manage; 2008 Jul; 36(1):e4-6. PubMed ID: 18538975 [No Abstract] [Full Text] [Related]
33. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Wallace MS; Rauck R; Fisher R; Charapata SG; Ellis D; Dissanayake S; Anesth Analg; 2008 Feb; 106(2):628-37, table of contents. PubMed ID: 18227325 [TBL] [Abstract][Full Text] [Related]